NI, CC, and DJ received a Baxter Healthcare Renal Discoveries Extramural Program Grant which partly funded the HONEYPOT trial. DJ is an International Society of Peritoneal Dialysis Councillor and is a current recipient of a Queensland Government Health Research Fellowship. ACUTE KIDNEY INJURY, ANALGESIC NEPHROPATHY AND TOXIN-MEDIATED KIDNEY INJURY IN AN AUSTRALIAN CHRONIC KIDNEY DISEASE (CKD) COHORT A Mallett, A Salisbury, Z Wang, HG Healy, WE Hoy AM as supported by a RBWH Foundation scholarship and Queensland Health. CKD.QLD is supported by Amgen, NHMRC Australia (Australian Fellowship: Hoy),
the Colonial Foundation of Australia, Queensland Health (in kind) and Roche. ALPORT SYNDROME AND THIN BASEMENT MEMBRANE NEPHROPATHY IN THE QUEENSLAND CHRONIC KIDNEY DISEASE (CKD) REGISTRY A Mallett, A Salisbury, Ixazomib nmr Z Wang, HG Healy, WE Hoy AM as supported by a RBWH Obeticholic Acid cell line Foundation scholarship and Queensland Health. CKD.QLD is supported by Amgen, NHMRC Australia (Australian Fellowship: Hoy), the Colonial Foundation of Australia, Queensland Health (in kind) and Roche. ANALYSIS OF THE COST-EFFECTIVENESS OF SWITCHING FROM SEVELAMER HYDROCHLORIDE TO LANTHANUM CARBONATE MONOTHERAPY: APPLICATIONS FOR AUSTRALIAN COSTS R Agnew, R Wilson, M Keith, J Brian Copely RA is an employee of Shire
Australia and stockholder of Shire Development LLC. APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) PROMOTES RENAL FIBROSIS AND APOPTOSIS IN THE OBSTRUCTED KIDNEY F Y Ma, D Breckenridge, D Nikolic-Paterson DB is an employee of Gilead Science. Gilead provided financial support for this study. DN-P is a consultant for Gilead. AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE IN AN AUSTRALIAN CHRONIC KIDNEY DISEASE (CKD) POPULATION A Mallett, A Salisbury, Z Wang, HG Healy, A Salisbury, WE Hoy AM is supported by a RBWH Foundation scholarship and Queensland Health. CKD.QLD is supported by Amgen, NHMRC Australia (Australian Fellowship: Hoy), the Colonial Foundation Lepirudin of Australia, Queensland Health (in kind) and Roche. BLOCKING THE NADPH OXIDASE NOX4 ACTIVITY PROVIDES RENOPROTECTION IN LONG TERM DIABETIC NEPHROPATHY J Jha, SP Gray, K Wingler, C Szyndralewiez, F Heitz,
ME Cooper, H HHW Schmidt, KA Jandeleit-Dahm CS and FH are paid employees and own shares of GenKyoTex SA, Geneva, Switzerland. All remaining authors report no conflicts. BLOCKADE OF SPLEEN TYROSINE KINASE (SYK) INHIBITS ANTIBODY-MEDIATED REJECTION IN RAT RENAL ALLOGRAFTS S Ramessur, F Ma, G Tesch, N Woodman, Y Han, K Blease, W Mulley, J Kanellis, D Nikolic-Paterson KB and D N-P are employees of Celgene CALCIPROTEIN-ASSOCIATED FETUIN-A CONCENTRATION IS ASSOCIATED WITH ALL-CAUSE MORTALITY IN PATIENTS WITH PRE-DIALYSIS CKD E Smith, L Tomlinson, M Ford, E Bodenham, L McMahon, Ci Rajkumar, S Holt ES, LM and SH have received research funding from Amgen and Baxter. ES has received honoraria from Shire. SH has received honoraria from Amgen, Baxter, Gilead and Shire.